{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:31:38Z","timestamp":1787869898587,"version":"build-2784847793"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K08600"],"award-info":[{"award-number":["23K08600"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K06758"],"award-info":[{"award-number":["23K06758"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Although several studies have investigated synovial sarcoma using established cell lines and mouse models, effective treatments remain limited. We treated five patients with synovial sarcoma at our institute between 2022 and 2023, and resected tumor specimens were cultured using a modified air\u2013liquid interface organoid method. After serial passaging and xenografting into NOD-scid IL2Rgnull (NSG) mice, patient-derived organoid lines were successfully established in three of five cases. These organoids exhibited stable propagation, tumorigenicity, and retained histological and genetic features of the original tumors, including\n                    <jats:italic>SS18\u2013SSX<\/jats:italic>\n                    fusion confirmed by polymerase chain reaction and Sanger sequencing. We then evaluated the organoids\u2019 response to a ferroptosis-inducing agent previously reported to be effective in synovial sarcoma. Despite low malic enzyme 1 (\n                    <jats:italic>ME1<\/jats:italic>\n                    ) expression, which has been associated with ferroptosis sensitivity, the established organoids were resistant to treatment. This unexpected result suggests additional mechanisms of resistance and highlights the complexity of ferroptosis regulation in synovial sarcoma. Our findings demonstrate the feasibility of establishing synovial sarcoma organoids using a modified culture method and suggest their potential as preclinical models for drug screening and mechanistic studies. These models provide a valuable resource for the development of novel therapeutic strategies for this rare and aggressive tumor.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-32030-w","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T02:44:07Z","timestamp":1766285047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of synovial sarcoma organoids exhibiting ferroptosis resistance despite low malic enzyme 1 expression"],"prefix":"10.1038","volume":"16","author":[{"given":"Toru","family":"Wakamatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Sasagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Nagamine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Shizuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironari","family":"Tamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Imura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinari","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Kakunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Yui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,21]]},"reference":[{"key":"32030_CR1","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3390\/curroncol28030177","volume":"28","author":"AM Gazendam","year":"2021","unstructured":"Gazendam, A. M. et al. Synovial Sarcoma: A Clinical Review. Curr. Oncol. 28, 1909\u20131920. https:\/\/doi.org\/10.3390\/curroncol28030177 (2021).","journal-title":"Curr. Oncol."},{"key":"32030_CR2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/jso.20804","volume":"97","author":"FC Eilber","year":"2008","unstructured":"Eilber, F. C. & Dry, S. M. Diagnosis and management of synovial sarcoma. J. Surg. Oncol. 97, 314\u2013320. https:\/\/doi.org\/10.1002\/jso.20804 (2008).","journal-title":"J. Surg. Oncol."},{"key":"32030_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.anndiagpath.2014.06.002","volume":"18","author":"K Thway","year":"2014","unstructured":"Thway, K. & Fisher, C. Synovial sarcoma: defining features and diagnostic evolution. Ann. Diagn. Pathol. 18, 369\u2013380. https:\/\/doi.org\/10.1016\/j.anndiagpath.2014.06.002 (2014).","journal-title":"Ann. Diagn. Pathol."},{"key":"32030_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1200\/JCO.2017.75.2041","volume":"36","author":"S Stacchiotti","year":"2018","unstructured":"Stacchiotti, S. & Van Tine, B. A. Synovial sarcoma: current concepts and future perspectives. J. Clin. Oncol. 36, 180\u2013187. https:\/\/doi.org\/10.1200\/JCO.2017.75.2041 (2018).","journal-title":"J. Clin. Oncol."},{"key":"32030_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/01.blo.0000128996.71921.62","volume":"419","author":"R Deshmukh","year":"2004","unstructured":"Deshmukh, R., Mankin, H. J. & Singer, S. Synovial sarcoma: The importance of size and location for survival. Clin. Orthop. Relat. Res. 419, 155\u2013161. https:\/\/doi.org\/10.1097\/01.blo.0000128996.71921.62 (2004).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"32030_CR6","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1148\/rg.265065115","volume":"26","author":"MD Murphey","year":"2006","unstructured":"Murphey, M. D. et al. Imaging of synovial sarcoma with radiologic-pathologic correlation. Radiographics 26, 1543\u20131565. https:\/\/doi.org\/10.1148\/rg.265065115 (2006).","journal-title":"Radiographics"},{"key":"32030_CR7","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1200\/JCO.2000.18.22.3794","volume":"18","author":"AJ Spillane","year":"2000","unstructured":"Spillane, A. J. et al. Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. J. Clin. Oncol. 18, 3794\u20133803. https:\/\/doi.org\/10.1200\/JCO.2000.18.22.3794 (2000).","journal-title":"J. Clin. Oncol."},{"key":"32030_CR8","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/cncr.20407","volume":"101","author":"A Ferrari","year":"2004","unstructured":"Ferrari, A. et al. Synovial sarcoma: A retrospective analysis of 271 patients of all ages treated at a single institution. Cancer 101, 627\u2013634. https:\/\/doi.org\/10.1002\/cncr.20407 (2004).","journal-title":"Cancer"},{"key":"32030_CR9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3892\/or.19.2.467","volume":"19","author":"S Takenaka","year":"2008","unstructured":"Takenaka, S. et al. Prognostic implication of SYT-SSX fusion type in synovial sarcoma: A multi-institutional retrospective analysis in Japan. Oncol. Rep. 19, 467\u2013476. https:\/\/doi.org\/10.3892\/or.19.2.467 (2008).","journal-title":"Oncol. Rep."},{"key":"32030_CR10","doi-asserted-by":"publisher","unstructured":"dos Santos, N. R., de Bruijn, D. R. H. & Geurts van Kessel, A. Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosom. Cancer 30, 1\u201314 (2001). https:\/\/doi.org\/10.1002\/gcc.1126","DOI":"10.1002\/gcc.1126"},{"key":"32030_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1158\/2159-8290.CD-14-0742","volume":"5","author":"TO Nielsen","year":"2015","unstructured":"Nielsen, T. O., Poulin, N. M. & Ladanyi, M. Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy. Cancer Discov. 5, 124\u2013134. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-0742 (2015).","journal-title":"Cancer Discov."},{"key":"32030_CR12","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.ccell.2018.05.007","volume":"33","author":"MJ McBride","year":"2018","unstructured":"McBride, M. J. et al. The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma. Cancer Cell 33, 1128\u20131141. https:\/\/doi.org\/10.1016\/j.ccell.2018.05.007 (2018).","journal-title":"Cancer Cell"},{"key":"32030_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cell.2013.02.036","volume":"153","author":"C Kadoch","year":"2013","unstructured":"Kadoch, C. & Crabtree, G. R. Reversible disruption of mSWI\/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma. Cell 153, 71\u201385. https:\/\/doi.org\/10.1016\/j.cell.2013.02.036 (2013).","journal-title":"Cell"},{"key":"32030_CR14","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1158\/2159-8290.CD-21-0324","volume":"11","author":"J Li","year":"2021","unstructured":"Li, J. et al. A role for SMARCB1 in synovial sarcomagenesis reveals that SS18-SSX induces canonical BAF destruction. Cancer Discov. 11, 2620\u20132637. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0324 (2021).","journal-title":"Cancer Discov."},{"key":"32030_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11864-018-0553-6","volume":"19","author":"IME Desar","year":"2018","unstructured":"Desar, I. M. E., Fleuren, E. D. G. & van der Graaf, W. T. A. Systemic treatment for adults with synovial sarcoma. Curr. Treat. Options Oncol. 19, 1\u201317. https:\/\/doi.org\/10.1007\/s11864-018-0553-6 (2018).","journal-title":"Curr. Treat. Options Oncol."},{"key":"32030_CR16","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3928\/01477447-20071201-05","volume":"30","author":"HJ Siegel","year":"2007","unstructured":"Siegel, H. J. et al. Synovial sarcoma: clinicopathologic features, treatment, and prognosis. Orthopedics 30, 1020. https:\/\/doi.org\/10.3928\/01477447-20071201-05 (2007).","journal-title":"Orthopedics"},{"key":"32030_CR17","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1097\/00005537-200211000-00010","volume":"112","author":"SS Kartha","year":"2002","unstructured":"Kartha, S. S. & Bumpous, J. M. Synovial cell sarcoma: diagnosis, treatment, and outcomes. Laryngoscope 112, 1979\u20131982. https:\/\/doi.org\/10.1097\/00005537-200211000-00010 (2002).","journal-title":"Laryngoscope"},{"key":"32030_CR18","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nm.1951","volume":"15","author":"A Ootani","year":"2009","unstructured":"Ootani, A. et al. Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche. Nat. Med. 15, 701\u2013706. https:\/\/doi.org\/10.1038\/nm.1951 (2009).","journal-title":"Nat. Med."},{"key":"32030_CR19","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1126\/science.aaw6985","volume":"364","author":"D Tuveson","year":"2019","unstructured":"Tuveson, D. & Clevers, H. Cancer modeling meets human organoid technology. Science 364, 952\u2013955. https:\/\/doi.org\/10.1126\/science.aaw6985 (2019).","journal-title":"Science"},{"key":"32030_CR20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","volume":"18","author":"J Drost","year":"2018","unstructured":"Drost, J. & Clevers, H. Organoids in cancer research. Nat. Rev. Cancer 18, 407\u2013418. https:\/\/doi.org\/10.1038\/s41568-018-0007-6 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"32030_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41563-021-01078-0","volume":"21","author":"BL LeSavage","year":"2022","unstructured":"LeSavage, B. L. et al. Next-generation cancer organoids. Nat. Mater. 21, 143\u2013159. https:\/\/doi.org\/10.1038\/s41563-021-01078-0 (2022).","journal-title":"Nat. Mater."},{"key":"32030_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.893592","volume":"12","author":"T Wakamatsu","year":"2022","unstructured":"Wakamatsu, T. et al. Establishment of organoids from human epithelioid sarcoma with the air-liquid interface organoid cultures. Front. Oncol. 12, 893592. https:\/\/doi.org\/10.3389\/fonc.2022.893592 (2022).","journal-title":"Front. Oncol."},{"key":"32030_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2023.100486","volume":"41","author":"R Suzuki","year":"2023","unstructured":"Suzuki, R. et al. Genetic characterization of a novel organoid from human malignant giant-cell tumor. J. Bone Oncol. 41, 100486. https:\/\/doi.org\/10.1016\/j.jbo.2023.100486 (2023).","journal-title":"J. Bone Oncol."},{"key":"32030_CR24","doi-asserted-by":"publisher","unstructured":"Boulay, G. et al. The chromatin landscape of primary synovial sarcoma organoids is linked to specific epigenetic mechanisms and dependencies. Life Sci. Alliance 4, e202000970 (2021). https:\/\/doi.org\/10.26508\/lsa.202000970","DOI":"10.26508\/lsa.202000970"},{"key":"32030_CR25","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/stem.450","volume":"28","author":"N Naka","year":"2010","unstructured":"Naka, N. et al. Synovial sarcoma is a stem cell malignancy. Stem Cells 28, 1119\u20131131. https:\/\/doi.org\/10.1002\/stem.450 (2010).","journal-title":"Stem Cells"},{"key":"32030_CR26","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1111\/cas.13078","volume":"107","author":"Y Imura","year":"2016","unstructured":"Imura, Y. et al. Functional and therapeutic relevance of hepatocyte growth factor\/c-MET signaling in synovial sarcoma. Cancer Sci. 107, 1867\u20131876. https:\/\/doi.org\/10.1111\/cas.13078 (2016).","journal-title":"Cancer Sci."},{"key":"32030_CR27","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3892\/ijo_00000537","volume":"36","author":"S Takenaka","year":"2010","unstructured":"Takenaka, S. et al. Downregulation of SS18-SSX1 expression in synovial sarcoma by small interfering RNA enhances the focal adhesion pathway and inhibits anchorage-independent growth in vitro and tumor growth in vivo. Int. J. Oncol. 36, 823\u2013831. https:\/\/doi.org\/10.3892\/ijo_00000537 (2010).","journal-title":"Int. J. Oncol."},{"key":"32030_CR28","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/cas.12468","volume":"105","author":"T Wakamatsu","year":"2014","unstructured":"Wakamatsu, T. et al. Deflection of vascular endothelial growth factor action by SS18-SSX and composite VEGF- and CXCR4-targeted therapy in synovial sarcoma. Cancer Sci. 105, 1124\u20131134. https:\/\/doi.org\/10.1111\/cas.12468 (2014).","journal-title":"Cancer Sci."},{"key":"32030_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.canlet.2003.10.017","volume":"204","author":"A Kawai","year":"2004","unstructured":"Kawai, A. et al. Establishment and characterization of a biphasic synovial sarcoma cell line, SYO-1. Cancer Lett. 204, 105\u2013113. https:\/\/doi.org\/10.1016\/j.canlet.2003.10.017 (2004).","journal-title":"Cancer Lett."},{"key":"32030_CR30","first-page":"498","volume":"67","author":"H Sonobe","year":"1992","unstructured":"Sonobe, H. et al. Establishment and characterization of a new human synovial sarcoma cell line. HS-SY-II. Lab. Invest. 67, 498\u2013505 (1992).","journal-title":"HS-SY-II. Lab. Invest."},{"key":"32030_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ccr.2007.02.019","volume":"11","author":"M Haldar","year":"2007","unstructured":"Haldar, M. et al. A conditional mouse model of synovial sarcoma: Insights into a myogenic origin. Cancer Cell 11, 375\u2013388. https:\/\/doi.org\/10.1016\/j.ccr.2007.02.019 (2007).","journal-title":"Cancer Cell"},{"key":"32030_CR32","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucl. Acids Res. 53, D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucl. Acids Res."},{"key":"32030_CR33","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"key":"32030_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucl. Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucl. Acids Res."},{"key":"32030_CR35","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1158\/1078-0432.CCR-22-0073","volume":"28","author":"CB Brashears","year":"2022","unstructured":"Brashears, C. B. et al. Malic enzyme 1 absence in synovial sarcoma shifts antioxidant system dependence and increases sensitivity to ferroptosis induction with ACXT-3102. Clin. Cancer Res. 28, 3573\u20133589. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-0073 (2022).","journal-title":"Clin. Cancer Res."},{"key":"32030_CR36","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.3390\/cancers15133484","volume":"15","author":"H Tamiya","year":"2023","unstructured":"Tamiya, H. et al. SHARPIN enhances ferroptosis in synovial sarcoma cells via NF-\u03baB- and PRMT5-mediated PGC1\u03b1 reduction. Cancers 15, 3484. https:\/\/doi.org\/10.3390\/cancers15133484 (2023).","journal-title":"Cancers"},{"key":"32030_CR37","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nature11776","volume":"493","author":"P Jiang","year":"2013","unstructured":"Jiang, P. et al. Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature 493, 689\u2013693. https:\/\/doi.org\/10.1038\/nature11776 (2013).","journal-title":"Nature"},{"key":"32030_CR38","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.3892\/or.2015.3760","volume":"33","author":"Y Imamura","year":"2015","unstructured":"Imamura, Y. et al. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer. Oncol. Rep. 33, 1837\u20131843. https:\/\/doi.org\/10.3892\/or.2015.3760 (2015).","journal-title":"Oncol. Rep."},{"key":"32030_CR39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/bit.26845","volume":"116","author":"AS Nunes","year":"2019","unstructured":"Nunes, A. S. et al. 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs. Biotechnol. Bioeng. 116, 206\u2013226. https:\/\/doi.org\/10.1002\/bit.26845 (2019).","journal-title":"Biotechnol. Bioeng."},{"key":"32030_CR40","doi-asserted-by":"publisher","unstructured":"Breslin, S. & O\u2019Driscoll, L. The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance. Oncotarget 7, 45745\u201345756 (2016). https:\/\/doi.org\/10.18632\/oncotarget.9935","DOI":"10.18632\/oncotarget.9935"},{"key":"32030_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2019.110264","volume":"107","author":"JC Fontoura","year":"2020","unstructured":"Fontoura, J. C. et al. Comparison of 2D and 3D cell culture models for cell growth, gene expression and drug resistance. Mater. Sci. Eng. C 107, 110264. https:\/\/doi.org\/10.1016\/j.msec.2019.110264 (2020).","journal-title":"Mater. Sci. Eng. C"},{"key":"32030_CR42","doi-asserted-by":"publisher","DOI":"10.1063\/5.0088795","volume":"16","author":"P De Stefano","year":"2022","unstructured":"De Stefano, P., Bianchi, E. & Dubini, G. The impact of microfluidics in high-throughput drug-screening applications. Biomicrofluidics 16, 034107. https:\/\/doi.org\/10.1063\/5.0088795 (2022).","journal-title":"Biomicrofluidics"},{"key":"32030_CR43","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.tips.2022.04.006","volume":"43","author":"Y Wang","year":"2022","unstructured":"Wang, Y. & Jeon, H. 3D cell cultures toward quantitative high-throughput drug screening. Trends Pharmacol. Sci. 43, 569\u2013581. https:\/\/doi.org\/10.1016\/j.tips.2022.04.006 (2022).","journal-title":"Trends Pharmacol. Sci."},{"key":"32030_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/ci.113","volume":"3","author":"S Sasagawa","year":"2024","unstructured":"Sasagawa, S. et al. Improvement of histone deacetylase inhibitor efficacy by SN38 through TWIST1 suppression in synovial sarcoma. Cancer Innov. 3, e113. https:\/\/doi.org\/10.1002\/ci.113 (2024).","journal-title":"Cancer Innov."},{"key":"32030_CR45","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s12859-018-2486-6","volume":"19","author":"SX Ge","year":"2018","unstructured":"Ge, S. X., Son, E. W. & Yao, R. iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data. BMC Bioinf. 19, 534. https:\/\/doi.org\/10.1186\/s12859-018-2486-6 (2018).","journal-title":"BMC Bioinf."},{"key":"32030_CR46","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1093\/bioinformatics\/btz854","volume":"36","author":"C Prieto","year":"2020","unstructured":"Prieto, C. & Barrios, D. RaNA-Seq: interactive RNA-Seq analysis from FASTQ files for functional analysis. Bioinformatics 36, 1955\u20131956. https:\/\/doi.org\/10.1093\/bioinformatics\/btz854 (2020).","journal-title":"Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32030-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32030-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32030-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:32:07Z","timestamp":1781623927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32030-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,21]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32030"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32030-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6871133\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,21]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2369"}}